Pmda - Pharmaceuticals and Medical Devices Agency

Jump to body

Navigation of each product type

Our recommended contents

Navigation of each product type

Our recommended contents

Here begins the text.

The Science Board

The 6th Term (FY2022, FY2023)

The 5th Term (FY2020, FY2021)

The 4th Term (FY2018, FY2019)

The 3rd Term (FY2016, FY2017)

The 2nd Term (FY2014, FY2015)

The 1st Term (FY2012, FY2013)

Regulatory Science/The Science Board/Standard Development

Regulatory Science
The Science Board
- Outline
- Outcome Documents of the Science Board
- The Science Board
  - The 6th Term (FY2022, FY2023)
  - The 5th Term (FY2020, FY2021)
  - The 4th Term (FY2018, FY2019)
  - The 3rd Term (FY2016, FY2017)
  - The 2nd Term (FY2014, FY2015)
  - The 1st Term (FY2012, FY2013)
- Subcommittees
  - Subcommittee on Cell and Gene Therapy Products Produced in vivo
  - Subcommittee on Software as a Medical Device Utilizing AI and Machine Learning
  - Subcommittee on Therapeutic Products Based on Extracellular Vesicles (EVs) Including Exosomes
  - Subcommittee on Computer Simulation
  - Subcommittee on Microbiome
  - Subcommittee on AMR
  - Subcommittee on Genome Editing
  - Subcommittee on Rare Cancers
  - Subcommittee on Pharmaceuticals Development
  - Subcommittee on AI (Artificial Intelligence)
  - Subcommittee on Placebo-controlled Studies
  - Subcommittee on Non-clinical Studies
  - Subcommittee on Application of Numerical Analysis to Non-clinical Evaluation
  - Subcommittee on Evaluation of Medical Devices in Pediatric Use
  - CPC (Cell Processing Center) Subcommittee
  - Pharmaceuticals Subcommittee
  - Bio-products Subcommittee
  - Medical Devices Subcommittee
  - Cellular and Tissue-based Products Subcommittee
Standard Development

Pmda - Pharmaceuticals and Medical Devices Agency

JCN 3010005007409

Shin-Kasumigaseki Building, 3-3-2 Kasumigaseki,
Chiyoda-ku, Tokyo 100-0013 Japan

Copyright (C) Pharmaceuticals and Medical Devices Agency, All Rights Reserved.